Literature DB >> 24179578

Combined treatment for cutaneous Rosai-Dorfman disease: a report of 2 cases.

Jian-Xin Xia1, Xian-Hua Jin, Yan Mou, Xue Li, Kai Yu, Wen-Jing Zhu, Fu-Qiu Li.   

Abstract

We report 2 cases of cutaneous Rosai-Dorfman disease (CRDD). One was a 46-year-old Chinese woman who presented with a 10-year history of multiple papules and nodules on the left cheek. Another one was a 57-year-old Chinese woman who presented with a 7-month history of erythematous pruritic plaque on the Dorsum nasi. Their lesions consisted of proliferative large histiocytes occasionally showing emperipolesis. Immunohistochemistry showed these histiocytes were positive for CD68 and S-100, but negative for CD1a. A diagnosis of CRDD was made. Their lesions were improved after intralesional treatment with Compound Betamethasone, interferon and acitretin. To our knowledge, we for the first time reported the application of intralesional Compound Betamethasone and Lidocaine, intramuscular injection of interferon, and oral acitretin in the treatment of CRDD, and favorable outcome was achieved without recurrence over a 1-year follow-up period.

Entities:  

Keywords:  Chinese; Cutaneous Rosai-Dorfman disease; intralesional Compound Betamethasone and lidocaine; intramuscular injection of interferon; oral acitretin

Year:  2013        PMID: 24179578      PMCID: PMC3798220     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  10 in total

1.  Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance.

Authors:  Chih-Chieh Chan; Chia-Yu Chu
Journal:  Arch Dermatol       Date:  2006-04

2.  Cutaneous rosai-dorfman disease persisting after surgical excision: report of a case treated with acitretin.

Authors:  Katherine Fening; Mark Bechtel; Sara Peters; Matthew Zirwas; Kamruz Darabi
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

3.  Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.

Authors:  K-H Wang; W-Y Chen; H-N Liu; C-C Huang; W-R Lee; C-H Hu
Journal:  Br J Dermatol       Date:  2006-02       Impact factor: 9.302

4.  Cutaneous Rosai-Dorfman disease following pneumococcal vaccination.

Authors:  Anastasia V Bassis; Janet A Fairley; Richard T Ameln; Brian L Swick
Journal:  J Am Acad Dermatol       Date:  2011-10       Impact factor: 11.527

5.  Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Authors:  J Rosai; R F Dorfman
Journal:  Arch Pathol       Date:  1969-01

6.  Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan.

Authors:  Ching-I Lu; Tseng-tong Kuo; Wen-Ron Wong; Hong-Shang Hong
Journal:  J Am Acad Dermatol       Date:  2004-12       Impact factor: 11.527

7.  Cutaneous rosai-dorfman disease: a clinical and histopathologic study of 25 cases in China.

Authors:  Yun-Yi Kong; Jin-Cheng Kong; Da-Ren Shi; Hong-Fen Lu; Xiong-Zeng Zhu; Jian Wang; Zhong-Wei Chen
Journal:  Am J Surg Pathol       Date:  2007-03       Impact factor: 6.394

8.  [Indolent firm reddish papules. Cutaneous Rosai-Dorfman disease].

Authors:  G Bens; R Kerdraon; J-J De Kyvon; E Estève
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

9.  Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.

Authors:  R Stadler; H G Otte; T Luger; B M Henz; P Kühl; T Zwingers; W Sterry
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

10.  Cutaneous Destombes-Rosai-Dorfman disease: absence of detection of HHV-6 and HHV-8 in skin.

Authors:  N Ortonne; A M Fillet; H Kosuge; M Bagot; C Frances; Janine Wechsler
Journal:  J Cutan Pathol       Date:  2002-02       Impact factor: 1.587

  10 in total
  4 in total

1.  Intramuscular nerve distribution in bladder and the relationship between intramuscular ganglia and bladder function in man and dog.

Authors:  Zeju Zhao; Qian Xu; Li Lu; Xu Luo; Xiaoyun Fu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  [Cutaneous Rosai-Dorfman syndrome. Successful therapy with intrralesional corticosteroids].

Authors:  S Vandersee; H-J Röwert-Huber; S Wöhner; C Loddenkemper; M Beyer; D Humme
Journal:  Hautarzt       Date:  2014-08       Impact factor: 0.751

3.  NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study.

Authors:  Kuan-Jou Wu; Shu-Hao Li; Jia-Bin Liao; Chien-Chun Chiou; Chieh-Shan Wu; Chien-Chin Chen
Journal:  Biology (Basel)       Date:  2021-05-02

4.  Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature.

Authors:  R C Maia; E de Meis; S Romano; J A Dobbin; C E Klumb
Journal:  Braz J Med Biol Res       Date:  2014-10-10       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.